BPC-157 Research Hub

A synthetic peptide with 15 amino acid residues, BPC-157 (Body Protection Compound-157) is derived from a partial sequence of a natural protein found in human gastric juice. Solid Phase Peptide Synthesis (SPPS) is used to create this synthetic peptide counterpart for use in experimental research. BPC-157 is a short linear peptide with a known amino acid sequence, which makes it appropriate for analytical characterization and laboratory research in contrast to recombinant proteins.

The peptide originated from research investigating biologically active protein fragments isolated from gastric-derived proteins, leading to the identification of a stable 15-amino acid sequence for further experimental evaluation. Since its initial characterisation, BPC-157 has become widely recognised in preclinical research for investigations into peptide pharmacology, molecular signalling and cell biology. Although the peptide has been examined extensively in laboratory and animal studies, its precise molecular mechanism continues to be investigated.

In laboratory situations the compound BPC-157 is usually employed in order to establish intracellular signalling pathways and peptide-protein interactions in preclinical experimental models, in biochemical tests and in cultured cell systems.

A synthetic linear peptide called BPC-157 (Body Protection Compound-157) is made up of 15 amino acid residues that are taken from a partial sequence of a protein found in human stomach juice. BPC-157 is a short peptide with a known amino acid sequence that does not go through intricate post-translational changes such as glycosylation, in contrast to bigger recombinant proteins.

Due to its relatively small size, BPC-157 does not possess a stable tertiary structure and is generally considered to exist as a flexible linear peptide in aqueous solution. Any transient secondary structural elements are influenced by environmental factors including pH, temperature, and solvent composition. The peptide is typically supplied as a lyophilised powder.

The physicochemical properties of BPC-157 are determined by its amino acid composition, which includes both hydrophilic and hydrophobic residues that influence its net charge, polarity and chromatographic behavior. The presence of multiple proline residues contributes to its conformational flexibility and has been investigated in relation to peptide stability.

Current laboratory investigations have examined BPC-157 as a synthetic 15-amino acid peptide with a molecular mechanism that has not yet been fully elucidated. Published experimental studies describe the peptide as interacting with multiple intracellular signalling pathways rather than a single, well-defined receptor target. Although numerous biochemical mechanisms have been investigated in vitro and in preclinical models, no primary molecular receptor has been conclusively identified.

In vitro models have explored the interaction of BPC-157 with signalling pathways associated with nitric oxide (NO) regulation. Experimental investigations have examined the peptide in relation to endothelial nitric oxide synthase (eNOS), nitric oxide production and downstream cyclic guanosine monophosphate (cGMP)-associated signalling using cultured cell systems and biochemical assays. These studies have characterised molecular interactions within nitric oxide signalling networks under controlled laboratory conditions.

Published experimental studies have also examined intracellular kinase pathways following exposure to BPC-157. Investigations have characterised signalling involving extracellular signal-regulated kinase (ERK1/2), focal adhesion kinase (FAK), phosphoinositide 3-kinase (PI3K)/Akt and related phosphorylation-dependent pathways using Western blotting, phosphoproteomic analysis and cell-based molecular techniques. These experiments have focused on defining changes in intracellular signal transduction rather than establishing physiological outcomes.

Current laboratory research has further investigated the interaction of BPC-157 with proteins involved in cytoskeletal organisation, cellular adhesion and extracellular matrix biology. Cell culture models have examined peptide-associated changes in protein expression, gene transcription and cell signalling using quantitative PCR, immunoblotting and fluorescence microscopy. Experimental studies have also investigated interactions with vascular endothelial growth factor (VEGF)-associated signalling pathways and angiogenesis-related molecular markers, although the precise relationship between BPC-157 and these signalling networks remains an active area of investigation.

The impact of BPC-157 on inflammatory signaling pathways, including molecular interactions involving nuclear factor kappa B (NF-κB) and cytokine-associated regulatory networks, has also been investigated in published studies. These studies, which have mostly been carried out in preclinical experimental systems, are still characterizing the intracellular signaling profile of the peptide.

Overall, the available literature characterises BPC-157 as a multifunctional investigational peptide whose molecular mechanism continues to be examined through biochemical assays, structural biology, molecular biology and preclinical research. The diversity of signalling pathways investigated suggests that its molecular activity has not yet been attributed to a single receptor or intracellular target.

Analytical verification of BPC-157 is carried out in order to determine if a research sample matches the molecular identity and purity specified. Techniques such as high-performance liquid chromatography (HPLC) can be used to assess the chromatographic purity and to identify any other detectable components in the sample.

Mass spectrometry (MS) offers additional molecular-mass data which can be used to assess the identity of peptides. When available, the batch-specific documentation such as a Certificate of Analysis (CoA) should be examined together with the analytical data in order to ensure traceability and to characterise the material supplied.

Store BPC-157 at 2–8°C, as specified on the supplied Certificate of Analysis. Keep the material protected from moisture, excessive heat, and direct light during storage.

Qualified laboratory personnel should handle BPC-157 with clean equipment and standard laboratory practices. Keep the container closed when not in use and take care to prevent contamination during handling. BPC-157 is intended for laboratory research use only.